1. Multi-Omics-Guided Discovery of Omicsynins Produced by Streptomyces sp. 1647: Pseudo-Tetrapeptides Active Against Influenza A Viruses and Coronavirus HCoV-229E
- Author
-
Yu-Huan Li, Zhen Xin, Li-Yan Yu, Yuanyuan Shi, Hongmin Sun, Kun Wang, Rong-Mei Gao, Bin Hong, Yihua Li, Minghua Chen, Yongsheng Che, Yexiang Wu, Shuyi Si, Yu Du, Xingxing Li, Jian-Dong Jiang, and Ming Zhong
- Subjects
Environmental Engineering ,General Computer Science ,Materials Science (miscellaneous) ,General Chemical Engineering ,Energy Engineering and Power Technology ,02 engineering and technology ,Secondary metabolite ,010402 general chemistry ,medicine.disease_cause ,01 natural sciences ,Streptomyces ,Virus ,Microbiology ,law.invention ,chemistry.chemical_compound ,Biosynthesis ,law ,medicine ,Gene ,Coronavirus ,Whole genome sequencing ,biology ,General Engineering ,021001 nanoscience & nanotechnology ,biology.organism_classification ,0104 chemical sciences ,chemistry ,Recombinant DNA ,0210 nano-technology ,medicine.drug - Abstract
Many microorganisms have mechanisms that protect cells against attack from viruses. The fermentation components of Streptomyces sp. 1647 exhibit potent anti-influenza A virus (IAV) activity. This strain was isolated from soil in southern China in the 1970s, but the chemical nature of its antiviral substance(s) has remained unknown until now. We used an integrated multi-omics strategy to identify the antiviral agents from this streptomycete. The antibiotics and Secondary Metabolite Analysis Shell (antiSMASH) analysis of its genome sequence revealed 38 biosynthetic gene clusters (BGCs) for secondary metabolites, and the target BGCs possibly responsible for the production of antiviral components were narrowed down to three BGCs by bioactivity-guided comparative transcriptomics analysis. Through bioinformatics analysis and genetic manipulation of the regulators and a biosynthetic gene, cluster 36 was identified as the BGC responsible for the biosynthesis of the antiviral compounds. Bioactivity-based molecular networking analysis of mass spectrometric data from different recombinant strains illustrated that the antiviral compounds were a class of structural analogues. Finally, 18 pseudo-tetrapeptides with an internal ureido linkage, omicsynins A1–A6, B1–B6, and C1–C6, were identified and/or isolated from fermentation broth. Among them, 11 compounds (omicsynins A1, A2, A6, B1–B3, B5, B6, C1, C2, and C6) are new compounds. Omicsynins B1–B4 exhibited potent antiviral activity against IAV with the 50% inhibitory concentration (IC50) of approximately 1 µmol∙L–1 and a selectivity index (SI) ranging from 100 to 300. Omicsynins B1–B4 also showed significant antiviral activity against human coronavirus HCoV-229E. By integrating multi-omics data, we discovered a number of novel antiviral pseudo-tetrapeptides produced by Streptomyces sp. 1647, indicating that the secondary metabolites of microorganisms are a valuable source of novel antivirals.
- Published
- 2022